49 /100
HIGH RISK
Score updated Feb 27, 2026
CHRS
Coherus Oncology, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when CHRS's score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
100
📊 Float Risk
63
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$252.61M
Shares Outstanding149.47M
Float108.52M
Cash$191.66M
Debt$54.32M
Short InterestN/A
🏛 Institutional Holdings
111 institutional holders · 54.48M shares
#1 BlackRock, Inc. 10.46M shares
#2 VANGUARD GROUP INC 10.32M shares
#3 TANG CAPITAL MANAGEMENT LLC 5.10M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest29.74M
Days to Cover18.0
% of Float27.4%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2021
xbrl XBRL WARRANT Dec 31, 2014
Full SEC filing analysis available with free account
📰 Recent News
Track CHRS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CHRS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required